Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment.

@article{Park2009PrognosticMT,
  title={Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment.},
  author={Min Jae Park and Jeeyun Lee and Jung Yong Hong and Moon Ki Choi and Joon Ho Yi and Su Jin Lee and Suk Joong Oh and Jin Seok Ahn and Keunchil Park and Myung Ju Ahn},
  journal={Cancer},
  year={2009},
  volume={115 7},
  pages={1518-30}
}
BACKGROUND A prognostic model based on clinical parameters for nonsmall cell lung cancer (NSCLC) patients treated with gefitinib (250 mg/day) as a salvage therapy was devised. METHODS Clinical data regarding a total of 316 metastatic or recurrent NSCLC patients who were treated with gefitinib were analyzed. RESULTS Poor prognostic factors for overall survival (OS) by multivariate analysis were an Eastern Cooperative Oncology Group (ECOG) performance status of 2 to 3 (hazards ratio [HR] of 2… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…